======= CBLL1 ======= == Gene Information == * **Official Symbol**: CBLL1 * **Official Name**: Cbl proto-oncogene like 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=79872|79872]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q75N03|Q75N03]] * **Interactions**: [[https://thebiogrid.org/search.php?search=CBLL1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20CBLL1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/606872|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Promotes ubiquitination of several tyrosine- phosphorylated Src substrates, including CDH1, CTTN and DOK1. Targets CDH1 for endocytosis and degradation. {ECO:0000250}. No Pfam Domain information is available for this gene. |entry of bacterium into host cell| |RNA N6-methyladenosine methyltransferase complex| |mRNA methylation| |mRNA modification| |RNA methylation| |positive regulation of endocytosis| |entry into host cell| |entry into host| |ubiquitin ligase complex| |interaction with host| |RNA modification| |regulation of endocytosis| |ubiquitin protein ligase activity| |ubiquitin-protein transferase activity| |macromolecule methylation| |negative regulation of cell adhesion| |methylation| |nuclear speck| |positive regulation of cell migration| |cell-cell adhesion| |positive regulation of cell motility| |positive regulation of cellular component movement| |regulation of vesicle-mediated transport| |positive regulation of locomotion| |regulation of cell adhesion| |protein ubiquitination| |mRNA metabolic process| |protein modification by small protein conjugation| |symbiotic process| |interspecies interaction between organisms| |regulation of cell migration| |regulation of cell motility| |cell adhesion| |biological adhesion| |regulation of locomotion| |protein modification by small protein conjugation or removal| |positive regulation of transport| |regulation of cellular component movement| |identical protein binding| |positive regulation of cellular component organization| |RNA metabolic process| |regulation of transport| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp128|GSK591 2.6μM R03 exp128]]|-1.75| |[[:results:exp537|WNT3A 44ng/ml R08 exp537]]|-1.75| |[[:results:exp439|QNZ 0.01μM R08 exp439]]|1.74| |[[:results:exp22|MLN-4924 2μM R00 exp22]]|1.82| |[[:results:exp294|Nutlin-3A 1.6μM R06 exp294]]|2.03| |[[:results:exp502|Milciclib 2μM R08 exp502]]|2.04| |[[:results:exp449|Arsenic trioxide 60μM R08 exp449]]|2.13| |[[:results:exp450|Artemisinin 50μM R08 exp450]]|2.24| |[[:results:exp468|CB-5083 0.4μM R08 exp468]]|2.26| |[[:results:exp264|Arsenate 40μM R06 exp264]]|2.42| |[[:results:exp478|Doxorubicin 0.02μM R08 exp478]]|2.83| |[[:results:exp504|MK2206 4μM R08 exp504]]|2.87| |[[:results:exp116|AICAR 240μM R03 exp116]]|3.19| |[[:results:exp365|I-BRD9 4μM R07 exp365]]|3.9| ^Gene^Correlation^ |[[:human genes:m:mettl14|METTL14]]|0.475| |[[:human genes:y:ythdf2|YTHDF2]]|0.471| |[[:human genes:c:cxorf56|CXorf56]]|0.465| |[[:human genes:d:dazap1|DAZAP1]]|0.415| |[[:human genes:r:rbm26|RBM26]]|0.413| |[[:human genes:d:dph1|DPH1]]|0.402| Global Fraction of Cell Lines Where Essential: 21/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|1/28| |blood|1/28| |bone|2/26| |breast|0/33| |central nervous system|2/56| |cervix|0/4| |colorectal|1/17| |esophagus|0/13| |fibroblast|0/1| |gastric|2/16| |kidney|0/21| |liver|1/20| |lung|2/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|1/16| |plasma cell|0/15| |prostate|0/1| |skin|1/24| |soft tissue|1/9| |thyroid|0/2| |upper aerodigestive|1/22| |urinary tract|2/29| |uterus|1/5| == Essentiality in NALM6 == * **Essentiality Rank**: 3958 * **Expression level (log2 read counts)**: 5.24 {{:chemogenomics:nalm6 dist.png?nolink |}}